Hologic generated $806.1 million in revenue in the three months ending July 1, a 12% year-over-year growth driven by the company's molecular diagnostics and international businesses. Chairman and CEO Steve MacMillan said the company is looking to release a new biopsy system in the US by year end, as well as two new mammography systems.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.